Saharsh Davuluri has been appointed as Chief Executive Officer and Managing Director of Neuland Laboratories Limited, marking a significant leadership transition for the Hyderabad-based pharmaceutical company. A long-time leader within the organization, Saharsh previously served as Vice Chairman & Managing Director and Joint Managing Director, building deep expertise across research and development, business strategy, and global CDMO operations.

Throughout his tenure, he has played a pivotal role in strengthening Neuland’s capabilities in complex APIs, peptides, and advanced chemistries, key areas driving innovation in the pharmaceutical sector. His leadership has also contributed to enhancing the company’s global footprint and fostering strong client partnerships.

In his new role, Saharsh is expected to focus on operational excellence, quality-driven execution, and expanding customer collaborations. His strategic vision is set to guide Neuland Laboratories into its next phase of sustainable growth and innovation, reinforcing its position as a trusted partner in the global pharma ecosystem.

CXO TechBOT wishes Saharsh Davuluri great success in his new role.